Some Investors Are Against the CoreWeave-Core Scientific Deal. Here's Why That Matters.
1. ISS recommends Core Scientific shareholders reject CoreWeave's acquisition deal. 2. Core Scientific shares rose, indicating positive market sentiment compared to CoreWeave's decline. 3. Investor confidence in Core Scientific's value appears stronger than the offered price. 4. Major shareholder Two Seas Capital plans to vote against the acquisition. 5. CoreWeave executives refuse to increase their $9 billion offer.